Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03110302 · ClinicalTrials.gov registry record · NA

In-Home Exposure Therapy for Veterans With Post Traumatic Stress Disorder (PTSD)

A NA study of Posttraumatic Stress Disorder, sponsored by Veterans Medical Research Foundation.

Completed
Registry status
NA
Development phase
175
Enrollment target
1
Study location

NCT03110302 is a NA study of Posttraumatic Stress Disorder that has completed, run by Veterans Medical Research Foundation. The registered enrollment target is 175 participants, above the 110-participant average among 117 other Posttraumatic Stress Disorder trials with a reported enrollment target (59% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03110302, a NA study of Posttraumatic Stress Disorder, has completed, sponsored by Veterans Medical Research Foundation.

COMPLETED
Registry status
NA
Development phase
175 participants
Enrollment target
1
Study location

Study Summary

This study examines clinical and process outcomes following variable length prolonged exposure (PE) for posttraumatic stress disorder (PTSD) delivered by one of three treatment modalities: home-based telehealth (HBT), office-based telehealth (OBT), or in-home-in-person (IHIP).

Interventions

  • BEHAVIORAL Prolonged exposure

Study Locations (1)

California

  • VA San Diego Healthcare System - San Diego

Trial Details

FieldValue
Enrollment Target 175 participants
Start Date 2012-10
Est. Completion 2018-07
Phase NA

What the Registry Record Tells You About NCT03110302

The ClinicalTrials.gov registry entry for NCT03110302 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 110-participant average among 117 other Posttraumatic Stress Disorder trials with a reported enrollment target (59% higher). The listed sponsor is Veterans Medical Research Foundation, which has 35 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Posttraumatic Stress Disorder appearing as the primary indexed condition, and to 1 intervention - of which Prolonged exposure is the first listed.

NCT03110302 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03110302 about?

NCT03110302 is a clinical study titled "In-Home Exposure Therapy for Veterans With Post Traumatic Stress Disorder (PTSD)". This study examines clinical and process outcomes following variable length prolonged exposure (PE) for posttraumatic stress disorder (PTSD) delivered by one of three treatment modalities: home-based telehealth (HBT), office-based telehealth (OBT), or in-home-in-person (IHIP).

What is the current status of trial NCT03110302?

This trial is currently completed. It is a NA study. The enrollment target is 175 participants. The study started on 2012-10. Estimated completion is 2018-07.

What conditions does trial NCT03110302 study?

This clinical trial studies the following conditions: Posttraumatic Stress Disorder.

What interventions are being tested in trial NCT03110302?

The interventions under investigation include: Prolonged exposure (BEHAVIORAL).

Who is sponsoring clinical trial NCT03110302?

This trial is sponsored by Veterans Medical Research Foundation, which has 35 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03110302 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Posttraumatic Stress Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.